The first crop in Maryland’s long-delayed medical cannabis program is mature and waiting for testing, but it is still unclear when patients might be able to buy it.
And industry officials caution that when it is ready for sale, there will not be nearly enough to meet market demand.
“This industry is in its infancy,” Patrick Jameson, executive director of the Maryland Medical Cannabis Commission, said Tuesday.
STATE BY STATE: Maryland Cannabis News
“No one should have any expectations,” he said. “The initial supply of medical cannabis will be limited."
The nascent industry has grown in fits and starts, beset by delays, court cases and a complete overhaul of the commission this summer.
On Tuesday afternoon, regulators approved eight more firms to enter the market — one grower, four processors, two independent testing labs and two dispensaries.
Top image: © Benkrut | Dreamstime.com
